These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 17958640

  • 1. Antiviral-resistant hepatitis B virus: can we prevent this monster from growing?
    Zoulim F, Buti M, Lok AS.
    J Viral Hepat; 2007 Nov; 14 Suppl 1():29-36. PubMed ID: 17958640
    [Abstract] [Full Text] [Related]

  • 2. Pathobiology of HBV mutants and clinical impact for treatment monitoring.
    Si Ahmed SN, Zoulim F.
    Expert Rev Anti Infect Ther; 2009 Apr; 7(3):309-20. PubMed ID: 19344244
    [Abstract] [Full Text] [Related]

  • 3. Management and prevention of drug resistance in chronic hepatitis B.
    Zoulim F, Durantel D, Deny P.
    Liver Int; 2009 Jan; 29 Suppl 1():108-15. PubMed ID: 19207973
    [Abstract] [Full Text] [Related]

  • 4. Antiviral therapy of chronic hepatitis B: prevention of drug resistance.
    Fournier C, Zoulim F.
    Clin Liver Dis; 2007 Nov; 11(4):869-92, ix. PubMed ID: 17981233
    [Abstract] [Full Text] [Related]

  • 5. Hepatitis B virus resistance to nucleos(t)ide analogues.
    Zoulim F, Locarnini S.
    Gastroenterology; 2009 Nov; 137(5):1593-608.e1-2. PubMed ID: 19737565
    [Abstract] [Full Text] [Related]

  • 6. Major causes of antiviral drug resistance and implications for treatment of hepatitis B virus monoinfection and coinfection with HIV.
    Locarnini S, Warner N.
    Antivir Ther; 2007 Nov; 12 Suppl 3():H15-23. PubMed ID: 18284179
    [Abstract] [Full Text] [Related]

  • 7. Selection of an entecavir-resistant mutant despite prolonged hepatitis B virus DNA suppression, in a chronic hepatitis B patient with preexistent lamivudine resistance: successful rescue therapy with tenofovir.
    Leemans WF, Niesters HG, van der Eijk AA, Janssen HL, Schalm SW, de Man RA.
    Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):773-7. PubMed ID: 18617782
    [Abstract] [Full Text] [Related]

  • 8. Chronic hepatitis B: preventing, detecting, and managing viral resistance.
    Keeffe EB, Dieterich DT, Pawlotsky JM, Benhamou Y.
    Clin Gastroenterol Hepatol; 2008 Mar; 6(3):268-74. PubMed ID: 18328434
    [Abstract] [Full Text] [Related]

  • 9. Drug resistance in antiviral therapy.
    Locarnini S, Bowden S.
    Clin Liver Dis; 2010 Aug; 14(3):439-59. PubMed ID: 20638024
    [Abstract] [Full Text] [Related]

  • 10. Antiviral drug resistance: clinical consequences and molecular aspects.
    Bartholomeusz A, Locarnini SA.
    Semin Liver Dis; 2006 May; 26(2):162-70. PubMed ID: 16673294
    [Abstract] [Full Text] [Related]

  • 11. Antiviral therapy of chronic hepatitis B.
    Zoulim F.
    Antiviral Res; 2006 Sep; 71(2-3):206-15. PubMed ID: 16716414
    [Abstract] [Full Text] [Related]

  • 12. Management of drug-resistant chronic hepatitis B.
    Fung SK, Fontana RJ.
    Clin Liver Dis; 2006 May; 10(2):275-302, viii. PubMed ID: 16971262
    [Abstract] [Full Text] [Related]

  • 13. Mechanism of viral persistence and resistance to nucleoside and nucleotide analogs in chronic hepatitis B virus infection.
    Zoulim F.
    Antiviral Res; 2004 Oct; 64(1):1-15. PubMed ID: 15451174
    [Abstract] [Full Text] [Related]

  • 14. Potential and limitations of lamivudine monotherapy in chronic hepatitis B: evidence from genotyping.
    Kennedy PT, Phillips N, Chandrasekhar J, Jacobs R, Jacobs M, Dusheiko G.
    Liver Int; 2008 May; 28(5):699-704. PubMed ID: 18433396
    [Abstract] [Full Text] [Related]

  • 15. Management of treatment failure in chronic hepatitis B.
    Zoulim F, Locarnini S.
    J Hepatol; 2012 May; 56 Suppl 1():S112-22. PubMed ID: 22300461
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of entecavir treatment for lamivudine-resistant hepatitis B over 3 years: histological improvement or entecavir resistance?
    Suzuki Y, Suzuki F, Kawamura Y, Yatsuji H, Sezaki H, Hosaka T, Akuta N, Kobayashi M, Saitoh S, Arase Y, Ikeda K, Kobayashi M, Miyakawa Y, Kumada H.
    J Gastroenterol Hepatol; 2009 Mar; 24(3):429-35. PubMed ID: 19226381
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Chronic hepatitis B: who to treat and which choice of treatment?
    Di Marco V, Craxì A.
    Expert Rev Anti Infect Ther; 2009 Apr; 7(3):281-91. PubMed ID: 19344242
    [Abstract] [Full Text] [Related]

  • 19. Entecavir: a potent antiviral with minimal long-term resistance in nucleoside-naive chronic hepatitis B patients.
    Cheng PN, Chang TT.
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):569-79. PubMed ID: 18847396
    [Abstract] [Full Text] [Related]

  • 20. Treatment of chronic hepatitis B.
    Loomba R, Liang TJ.
    Antivir Ther; 2007 Oct; 12 Suppl 3():H33-41. PubMed ID: 18284181
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.